1Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet,2000,355(9212) : 1303
2Wegner JA, Dinardo JA, Arabia FA, et al. Blood loss and transfusion requirements in patients implanted with a mechanical circulatory support device undergoing cardiac transplantation. J Heart Lung Transplant,2000, 19(5) :504
3West LJ, Pollock-Barziv SM, Dipchand Al,et al. ABO-incompatible heart transplantation in infants. N Engl J Med,2001,344(11):793
4Ramsey G, Sherman LA. The new age of organic blood banking. Transfusion, 1998 , 38 ( 1 ): 9
5Laine E, Steadman R, Calhoun L, et al. Comparison of RBCs and FFP with whole blood during liver transplant surgery. Transfusion,2003,43(3) :322
6Dalman A, Sabate A, Acosta F,et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg, 2000, 91 ( 1 ): 29
7Triulzi DJ, Nalesnik MA, Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion, 2001,41 (3):419
8Barr ML, Meiser BM, Eisen HJ,et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med, 1998 , 339(24):1744
9Tanabe K, Takahashi K, Sonda K,et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation, 1998,65(2): 224
10Nelson PW, Landreneau MD, Luger AM,et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients.Transplantation, 1998,65 (2): 256
